CS logo
small CS logo
Synexus Clinical Research US, Inc.

Atlanta, Georgia, United States
Doctor in Sandy Springs, Georgia
6065 Roswell Rd # 820, Atlanta, GA 30328

About Synexus Clinical Research US, Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Synexus Clinical Research US, Inc.


During the past decade, Synexus Clinical Research US, Inc. conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 9 clinical trials were completed, i.e. on average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
2003-06-01
2019-09-01
Completed
64
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
2003-06-01
2022-12-22
Completed
588
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066

Rows per page:

1–100 of 250

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Synexus Clinical Research US, Inc." #1 sponsor was "Allergan" with 3 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Karuna Therapeutics" with 3 trials sponsored, "ACADIA Pharmaceuticals Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc." #1 collaborator was "Cognitive Research Corporation" with 1 trials as a collaborator and "Neumora Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Synexus Clinical Research US, Inc.


According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc." are "Schizophrenia" (10 trials), "Episodic Migraine" (3 trials), "Adjunctive Treatment of Major Depressive Disorder" (2 trials), "Depressive Disorder, Major" (2 trials) and "Lower Respiratory Tract Disease" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Synexus Clinical Research US, Inc.


Most popular intervention types in "Synexus Clinical Research US, Inc." are "Drug" (18 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Atogepant" (3 trials), "Xanomeline and Trospium Chloride Capsules" (3 trials), "Pimavanserin" (2 trials) and "Seltorexant" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Synexus Clinical Research US, Inc.


The vast majority of trials in "Synexus Clinical Research US, Inc." are 20 trials for "All" genders.

Clinical Trials Status at Synexus Clinical Research US, Inc.


Currently, there are NaN active trials in "Synexus Clinical Research US, Inc.". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Synexus Clinical Research US, Inc., undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research US, Inc., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status